J 2003

Inhibition of cannabinoid CB1 receptor attenuates behavioural sensitization to methamphetamine in mice

LANDA, Leoš, Karel ŠLAIS and Alexandra ŠULCOVÁ

Basic information

Original name

Inhibition of cannabinoid CB1 receptor attenuates behavioural sensitization to methamphetamine in mice

Authors

LANDA, Leoš (203 Czech Republic), Karel ŠLAIS (203 Czech Republic) and Alexandra ŠULCOVÁ (203 Czech Republic, guarantor)

Edition

European Neuropsychopharmacology, Amsterdam, Elsevier, 2003, 0924-977X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.842

RIV identification code

RIV/00216224:14110/03:00008970

Organization unit

Faculty of Medicine

UT WoS

000185412300676

Keywords in English

AM 251; behavioral sensitization; locomotor/exploratory activity; mice

Tags

International impact
Změněno: 30/11/2006 13:23, doc. Mgr. MVDr. Leoš Landa, Ph.D.

Abstract

V originále

Behavioural sensitization is typically manifested by increased behavioural responses to the drug. In our previous studies we created an original dosage regimen that produced sensitization to methamphetamine effects on locomotor/exploratory behaviour in mice and also cross-sensitization to methamphetamine with the cannabinoid receptor agonist methanandamide. The changes in the behaviour were recorded in the open field of the Actitrack apparatus (Panlab, S. L., Spain). Methamphetamine and combined methamphetamine+AM 251 treatments were injected to the mice at the doses of 2.5 mg/kg and 5 mg/kg, respectively. On the day 8 all mice were given a "challenge dose" of methamphetamine 2.5 mg/kg to check a development of hypothesised sensitization. In the group pre-treated with methamphetamine only, a significant behavioural sensitization occurred, whereas in the group pre-treated with the combination of methamphetamine and selective CB1 receptor antagonist AM 251 behavioural responses were significantly lower compared to methamphetamine sensitized animals.